SPOTLIGHT -
Chicago-As progress continues to be seen in technology for identifying structural and functional glaucomatous changes, ophthalmologists may be wondering whether and how to incorporate those modalities into their practices.
ABVC BioPharma reaches global licensing deal for ophthalmology pipeline
EyePod: Modifier Gene Therapy: What is it?
Astellas receives permanent J-code for avacincaptad pegol intravitreal solution for GA
EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery
RadiusXR publishes NOVA clinical trial results for virtual reality perimetry
Belite Bio completes submission to PMDA to initiate Dragon II trial of Tinlarebant for the treatment of adolescent Stargardt disease in Japan